Regenerex Pharma (RGPX) Invested Capital (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Invested Capital data on file, last reported at -$4.7 million in Q3 2025.

• Invested Capital for Q3 2025 came in at -$4.7 million, up 1.23% year-over-year; the trailing twelve-month figure through Sep 2025 was -$4.7 million (up 1.23% YoY), and the FY2025 annual result was -$4.2 million, down 2.32% from the prior year.
• Invested Capital fell to -$4.7 million in Q3 2025 per RGPX's latest filing, from -$4.5 million in the prior quarter.
• Over five years, Invested Capital peaked at -$704034.0 in Q1 2021 and troughed at -$5.1 million in Q4 2024.
• A 5-year average of -$2.5 million and a median of -$1.1 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2023 and 2025: Invested Capital sank 310.27% in 2023, then grew 1.23% in 2025.
• A 5-year view of Invested Capital shows it stood at -$937068.0 in 2021, then fell by 0.82% to -$944770.0 in 2022, then slumped by 310.27% to -$3.9 million in 2023, then tumbled by 30.38% to -$5.1 million in 2024, then advanced by 7.02% to -$4.7 million in 2025.
• Business Quant data shows RGPX's Invested Capital at -$4.7 million in Q3 2025, -$4.5 million in Q2 2025, and -$4.2 million in Q1 2025.